nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—ABCB1—ulcerative colitis	0.236	1	CbGaD
Paroxetine—CYP2B6—Nicotine—ulcerative colitis	0.0452	0.113	CbGbCtD
Paroxetine—CYP2B6—Cholecalciferol—ulcerative colitis	0.0405	0.101	CbGbCtD
Paroxetine—CYP2C8—Nicotine—ulcerative colitis	0.0342	0.0856	CbGbCtD
Paroxetine—CYP2C8—Cholecalciferol—ulcerative colitis	0.0307	0.0768	CbGbCtD
Paroxetine—CYP2C9—Nicotine—ulcerative colitis	0.0239	0.0597	CbGbCtD
Paroxetine—ABCB1—Methylprednisolone—ulcerative colitis	0.0238	0.0595	CbGbCtD
Paroxetine—CYP2D6—Nicotine—ulcerative colitis	0.0218	0.0546	CbGbCtD
Paroxetine—CYP2C9—Cholecalciferol—ulcerative colitis	0.0214	0.0536	CbGbCtD
Paroxetine—CYP2C8—Hydrocortisone—ulcerative colitis	0.0213	0.0535	CbGbCtD
Paroxetine—CYP2D6—Cholecalciferol—ulcerative colitis	0.0196	0.049	CbGbCtD
Paroxetine—CYP2B6—Dexamethasone—ulcerative colitis	0.0175	0.0439	CbGbCtD
Paroxetine—ABCB1—Betamethasone—ulcerative colitis	0.0154	0.0387	CbGbCtD
Paroxetine—ABCB1—Prednisolone—ulcerative colitis	0.0152	0.0382	CbGbCtD
Paroxetine—ABCB1—Hydrocortisone—ulcerative colitis	0.0144	0.0362	CbGbCtD
Paroxetine—ABCB1—Prednisone—ulcerative colitis	0.0144	0.036	CbGbCtD
Paroxetine—CYP2C8—Dexamethasone—ulcerative colitis	0.0133	0.0332	CbGbCtD
Paroxetine—CYP2C9—Dexamethasone—ulcerative colitis	0.00926	0.0232	CbGbCtD
Paroxetine—ABCB1—Dexamethasone—ulcerative colitis	0.00898	0.0225	CbGbCtD
Paroxetine—CYP2D6—Dexamethasone—ulcerative colitis	0.00847	0.0212	CbGbCtD
Paroxetine—CHRM3—muscle of abdomen—ulcerative colitis	0.00699	0.223	CbGeAlD
Paroxetine—HTR2A—enteric nervous system—ulcerative colitis	0.00655	0.209	CbGeAlD
Paroxetine—HTR2A—myenteric nerve plexus—ulcerative colitis	0.00497	0.159	CbGeAlD
Paroxetine—TACR1—smooth muscle tissue—ulcerative colitis	0.00195	0.0623	CbGeAlD
Paroxetine—TACR1—digestive system—ulcerative colitis	0.00154	0.0492	CbGeAlD
Paroxetine—CHRM5—epithelium—ulcerative colitis	0.00149	0.0475	CbGeAlD
Paroxetine—CHRM3—smooth muscle tissue—ulcerative colitis	0.000802	0.0256	CbGeAlD
Paroxetine—SLC6A4—digestive system—ulcerative colitis	0.000711	0.0227	CbGeAlD
Paroxetine—CHRM3—digestive system—ulcerative colitis	0.000634	0.0202	CbGeAlD
Paroxetine—HTR2A—epithelium—ulcerative colitis	0.000494	0.0158	CbGeAlD
Paroxetine—HTR2A—smooth muscle tissue—ulcerative colitis	0.000476	0.0152	CbGeAlD
Paroxetine—CYP2B6—lymphoid tissue—ulcerative colitis	0.000467	0.0149	CbGeAlD
Paroxetine—CYP2B6—digestive system—ulcerative colitis	0.000461	0.0147	CbGeAlD
Paroxetine—CYP2C9—digestive system—ulcerative colitis	0.000457	0.0146	CbGeAlD
Paroxetine—CYP2C8—liver—ulcerative colitis	0.000383	0.0122	CbGeAlD
Paroxetine—HTR2A—digestive system—ulcerative colitis	0.000376	0.012	CbGeAlD
Paroxetine—CYP2B6—liver—ulcerative colitis	0.000343	0.011	CbGeAlD
Paroxetine—CYP2D6—digestive system—ulcerative colitis	0.000343	0.0109	CbGeAlD
Paroxetine—CYP2C9—liver—ulcerative colitis	0.00034	0.0109	CbGeAlD
Paroxetine—ABCB1—epithelium—ulcerative colitis	0.000324	0.0103	CbGeAlD
Paroxetine—HTR2A—liver—ulcerative colitis	0.00028	0.00894	CbGeAlD
Paroxetine—CYP2D6—liver—ulcerative colitis	0.000255	0.00815	CbGeAlD
Paroxetine—ABCB1—lymphoid tissue—ulcerative colitis	0.000249	0.00796	CbGeAlD
Paroxetine—ABCB1—digestive system—ulcerative colitis	0.000246	0.00787	CbGeAlD
Paroxetine—ABCB1—liver—ulcerative colitis	0.000184	0.00586	CbGeAlD
Paroxetine—Vomiting—Azathioprine—ulcerative colitis	6.46e-05	0.000242	CcSEcCtD
Paroxetine—Nervous system disorder—Hydrocortisone—ulcerative colitis	6.46e-05	0.000242	CcSEcCtD
Paroxetine—Myalgia—Methylprednisolone—ulcerative colitis	6.45e-05	0.000242	CcSEcCtD
Paroxetine—Arthralgia—Methylprednisolone—ulcerative colitis	6.45e-05	0.000242	CcSEcCtD
Paroxetine—Eye disorder—Prednisone—ulcerative colitis	6.44e-05	0.000241	CcSEcCtD
Paroxetine—Anxiety—Methylprednisolone—ulcerative colitis	6.43e-05	0.000241	CcSEcCtD
Paroxetine—Tachycardia—Hydrocortisone—ulcerative colitis	6.43e-05	0.000241	CcSEcCtD
Paroxetine—Rash—Azathioprine—ulcerative colitis	6.41e-05	0.00024	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	6.41e-05	0.00024	CcSEcCtD
Paroxetine—Dermatitis—Azathioprine—ulcerative colitis	6.4e-05	0.00024	CcSEcCtD
Paroxetine—Flushing—Prednisone—ulcerative colitis	6.4e-05	0.00024	CcSEcCtD
Paroxetine—Skin disorder—Hydrocortisone—ulcerative colitis	6.39e-05	0.00024	CcSEcCtD
Paroxetine—Ill-defined disorder—Dexamethasone—ulcerative colitis	6.39e-05	0.00024	CcSEcCtD
Paroxetine—Ill-defined disorder—Betamethasone—ulcerative colitis	6.39e-05	0.00024	CcSEcCtD
Paroxetine—Discomfort—Triamcinolone—ulcerative colitis	6.39e-05	0.000239	CcSEcCtD
Paroxetine—Discomfort—Methylprednisolone—ulcerative colitis	6.37e-05	0.000239	CcSEcCtD
Paroxetine—Headache—Azathioprine—ulcerative colitis	6.37e-05	0.000238	CcSEcCtD
Paroxetine—Hyperhidrosis—Hydrocortisone—ulcerative colitis	6.36e-05	0.000238	CcSEcCtD
Paroxetine—Diarrhoea—Mesalazine—ulcerative colitis	6.33e-05	0.000237	CcSEcCtD
Paroxetine—Dry mouth—Triamcinolone—ulcerative colitis	6.32e-05	0.000237	CcSEcCtD
Paroxetine—Angioedema—Dexamethasone—ulcerative colitis	6.3e-05	0.000236	CcSEcCtD
Paroxetine—Angioedema—Betamethasone—ulcerative colitis	6.3e-05	0.000236	CcSEcCtD
Paroxetine—Angiopathy—Prednisone—ulcerative colitis	6.26e-05	0.000234	CcSEcCtD
Paroxetine—Confusional state—Methylprednisolone—ulcerative colitis	6.24e-05	0.000234	CcSEcCtD
Paroxetine—Immune system disorder—Prednisone—ulcerative colitis	6.23e-05	0.000233	CcSEcCtD
Paroxetine—Malaise—Betamethasone—ulcerative colitis	6.21e-05	0.000233	CcSEcCtD
Paroxetine—Malaise—Dexamethasone—ulcerative colitis	6.21e-05	0.000233	CcSEcCtD
Paroxetine—Anaphylactic shock—Triamcinolone—ulcerative colitis	6.2e-05	0.000232	CcSEcCtD
Paroxetine—Oedema—Triamcinolone—ulcerative colitis	6.2e-05	0.000232	CcSEcCtD
Paroxetine—Vertigo—Dexamethasone—ulcerative colitis	6.19e-05	0.000232	CcSEcCtD
Paroxetine—Vertigo—Betamethasone—ulcerative colitis	6.19e-05	0.000232	CcSEcCtD
Paroxetine—Anaphylactic shock—Methylprednisolone—ulcerative colitis	6.19e-05	0.000232	CcSEcCtD
Paroxetine—Syncope—Betamethasone—ulcerative colitis	6.18e-05	0.000232	CcSEcCtD
Paroxetine—Syncope—Dexamethasone—ulcerative colitis	6.18e-05	0.000232	CcSEcCtD
Paroxetine—Arrhythmia—Prednisone—ulcerative colitis	6.16e-05	0.000231	CcSEcCtD
Paroxetine—Infection—Triamcinolone—ulcerative colitis	6.16e-05	0.000231	CcSEcCtD
Paroxetine—Hypotension—Hydrocortisone—ulcerative colitis	6.15e-05	0.00023	CcSEcCtD
Paroxetine—Infection—Methylprednisolone—ulcerative colitis	6.14e-05	0.00023	CcSEcCtD
Paroxetine—Dizziness—Mesalazine—ulcerative colitis	6.12e-05	0.000229	CcSEcCtD
Paroxetine—Shock—Triamcinolone—ulcerative colitis	6.1e-05	0.000228	CcSEcCtD
Paroxetine—Insomnia—Prednisolone—ulcerative colitis	6.1e-05	0.000228	CcSEcCtD
Paroxetine—Alopecia—Prednisone—ulcerative colitis	6.09e-05	0.000228	CcSEcCtD
Paroxetine—Shock—Methylprednisolone—ulcerative colitis	6.09e-05	0.000228	CcSEcCtD
Paroxetine—Nervous system disorder—Methylprednisolone—ulcerative colitis	6.07e-05	0.000227	CcSEcCtD
Paroxetine—Loss of consciousness—Dexamethasone—ulcerative colitis	6.06e-05	0.000227	CcSEcCtD
Paroxetine—Loss of consciousness—Betamethasone—ulcerative colitis	6.06e-05	0.000227	CcSEcCtD
Paroxetine—Paraesthesia—Prednisolone—ulcerative colitis	6.05e-05	0.000227	CcSEcCtD
Paroxetine—Tachycardia—Triamcinolone—ulcerative colitis	6.05e-05	0.000227	CcSEcCtD
Paroxetine—Mental disorder—Prednisone—ulcerative colitis	6.04e-05	0.000226	CcSEcCtD
Paroxetine—Nausea—Azathioprine—ulcerative colitis	6.04e-05	0.000226	CcSEcCtD
Paroxetine—Tachycardia—Methylprednisolone—ulcerative colitis	6.04e-05	0.000226	CcSEcCtD
Paroxetine—Skin disorder—Methylprednisolone—ulcerative colitis	6.01e-05	0.000225	CcSEcCtD
Paroxetine—Malnutrition—Prednisone—ulcerative colitis	6e-05	0.000225	CcSEcCtD
Paroxetine—Erythema—Prednisone—ulcerative colitis	6e-05	0.000225	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	6e-05	0.000225	CcSEcCtD
Paroxetine—Hyperhidrosis—Triamcinolone—ulcerative colitis	5.99e-05	0.000224	CcSEcCtD
Paroxetine—Hyperhidrosis—Methylprednisolone—ulcerative colitis	5.98e-05	0.000224	CcSEcCtD
Paroxetine—Convulsion—Betamethasone—ulcerative colitis	5.97e-05	0.000224	CcSEcCtD
Paroxetine—Convulsion—Dexamethasone—ulcerative colitis	5.97e-05	0.000224	CcSEcCtD
Paroxetine—Insomnia—Hydrocortisone—ulcerative colitis	5.95e-05	0.000223	CcSEcCtD
Paroxetine—Hypertension—Dexamethasone—ulcerative colitis	5.95e-05	0.000223	CcSEcCtD
Paroxetine—Hypertension—Betamethasone—ulcerative colitis	5.95e-05	0.000223	CcSEcCtD
Paroxetine—Paraesthesia—Hydrocortisone—ulcerative colitis	5.91e-05	0.000221	CcSEcCtD
Paroxetine—Vomiting—Mesalazine—ulcerative colitis	5.89e-05	0.00022	CcSEcCtD
Paroxetine—Myalgia—Dexamethasone—ulcerative colitis	5.87e-05	0.00022	CcSEcCtD
Paroxetine—Myalgia—Betamethasone—ulcerative colitis	5.87e-05	0.00022	CcSEcCtD
Paroxetine—Anxiety—Betamethasone—ulcerative colitis	5.85e-05	0.000219	CcSEcCtD
Paroxetine—Anxiety—Dexamethasone—ulcerative colitis	5.85e-05	0.000219	CcSEcCtD
Paroxetine—Rash—Mesalazine—ulcerative colitis	5.84e-05	0.000219	CcSEcCtD
Paroxetine—Dermatitis—Mesalazine—ulcerative colitis	5.83e-05	0.000218	CcSEcCtD
Paroxetine—Headache—Mesalazine—ulcerative colitis	5.8e-05	0.000217	CcSEcCtD
Paroxetine—Discomfort—Betamethasone—ulcerative colitis	5.8e-05	0.000217	CcSEcCtD
Paroxetine—Discomfort—Dexamethasone—ulcerative colitis	5.8e-05	0.000217	CcSEcCtD
Paroxetine—Dyspepsia—Hydrocortisone—ulcerative colitis	5.8e-05	0.000217	CcSEcCtD
Paroxetine—Hypotension—Methylprednisolone—ulcerative colitis	5.78e-05	0.000216	CcSEcCtD
Paroxetine—Pain—Prednisolone—ulcerative colitis	5.76e-05	0.000216	CcSEcCtD
Paroxetine—Decreased appetite—Hydrocortisone—ulcerative colitis	5.72e-05	0.000214	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	5.68e-05	0.000213	CcSEcCtD
Paroxetine—Fatigue—Hydrocortisone—ulcerative colitis	5.68e-05	0.000213	CcSEcCtD
Paroxetine—Vision blurred—Prednisone—ulcerative colitis	5.66e-05	0.000212	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	5.65e-05	0.000212	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	5.64e-05	0.000211	CcSEcCtD
Paroxetine—Pain—Hydrocortisone—ulcerative colitis	5.63e-05	0.000211	CcSEcCtD
Paroxetine—Anaphylactic shock—Dexamethasone—ulcerative colitis	5.62e-05	0.000211	CcSEcCtD
Paroxetine—Oedema—Dexamethasone—ulcerative colitis	5.62e-05	0.000211	CcSEcCtD
Paroxetine—Oedema—Betamethasone—ulcerative colitis	5.62e-05	0.000211	CcSEcCtD
Paroxetine—Anaphylactic shock—Betamethasone—ulcerative colitis	5.62e-05	0.000211	CcSEcCtD
Paroxetine—Insomnia—Triamcinolone—ulcerative colitis	5.61e-05	0.00021	CcSEcCtD
Paroxetine—Insomnia—Methylprednisolone—ulcerative colitis	5.59e-05	0.00021	CcSEcCtD
Paroxetine—Infection—Dexamethasone—ulcerative colitis	5.59e-05	0.000209	CcSEcCtD
Paroxetine—Infection—Betamethasone—ulcerative colitis	5.59e-05	0.000209	CcSEcCtD
Paroxetine—Ill-defined disorder—Prednisone—ulcerative colitis	5.57e-05	0.000209	CcSEcCtD
Paroxetine—Paraesthesia—Triamcinolone—ulcerative colitis	5.57e-05	0.000208	CcSEcCtD
Paroxetine—Feeling abnormal—Prednisolone—ulcerative colitis	5.55e-05	0.000208	CcSEcCtD
Paroxetine—Paraesthesia—Methylprednisolone—ulcerative colitis	5.55e-05	0.000208	CcSEcCtD
Paroxetine—Anaemia—Prednisone—ulcerative colitis	5.55e-05	0.000208	CcSEcCtD
Paroxetine—Shock—Dexamethasone—ulcerative colitis	5.53e-05	0.000207	CcSEcCtD
Paroxetine—Shock—Betamethasone—ulcerative colitis	5.53e-05	0.000207	CcSEcCtD
Paroxetine—Dyspnoea—Triamcinolone—ulcerative colitis	5.53e-05	0.000207	CcSEcCtD
Paroxetine—Nervous system disorder—Betamethasone—ulcerative colitis	5.52e-05	0.000207	CcSEcCtD
Paroxetine—Nervous system disorder—Dexamethasone—ulcerative colitis	5.52e-05	0.000207	CcSEcCtD
Paroxetine—Agitation—Prednisone—ulcerative colitis	5.52e-05	0.000207	CcSEcCtD
Paroxetine—Thrombocytopenia—Betamethasone—ulcerative colitis	5.51e-05	0.000206	CcSEcCtD
Paroxetine—Thrombocytopenia—Dexamethasone—ulcerative colitis	5.51e-05	0.000206	CcSEcCtD
Paroxetine—Nausea—Mesalazine—ulcerative colitis	5.5e-05	0.000206	CcSEcCtD
Paroxetine—Tachycardia—Dexamethasone—ulcerative colitis	5.49e-05	0.000206	CcSEcCtD
Paroxetine—Tachycardia—Betamethasone—ulcerative colitis	5.49e-05	0.000206	CcSEcCtD
Paroxetine—Angioedema—Prednisone—ulcerative colitis	5.48e-05	0.000205	CcSEcCtD
Paroxetine—Dyspepsia—Triamcinolone—ulcerative colitis	5.46e-05	0.000204	CcSEcCtD
Paroxetine—Dyspepsia—Methylprednisolone—ulcerative colitis	5.44e-05	0.000204	CcSEcCtD
Paroxetine—Hyperhidrosis—Dexamethasone—ulcerative colitis	5.44e-05	0.000204	CcSEcCtD
Paroxetine—Hyperhidrosis—Betamethasone—ulcerative colitis	5.44e-05	0.000204	CcSEcCtD
Paroxetine—Feeling abnormal—Hydrocortisone—ulcerative colitis	5.43e-05	0.000203	CcSEcCtD
Paroxetine—Malaise—Prednisone—ulcerative colitis	5.41e-05	0.000203	CcSEcCtD
Paroxetine—Vertigo—Prednisone—ulcerative colitis	5.39e-05	0.000202	CcSEcCtD
Paroxetine—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	5.38e-05	0.000202	CcSEcCtD
Paroxetine—Syncope—Prednisone—ulcerative colitis	5.38e-05	0.000202	CcSEcCtD
Paroxetine—Urticaria—Prednisolone—ulcerative colitis	5.36e-05	0.000201	CcSEcCtD
Paroxetine—Fatigue—Triamcinolone—ulcerative colitis	5.34e-05	0.0002	CcSEcCtD
Paroxetine—Fatigue—Methylprednisolone—ulcerative colitis	5.33e-05	0.0002	CcSEcCtD
Paroxetine—Pain—Triamcinolone—ulcerative colitis	5.3e-05	0.000199	CcSEcCtD
Paroxetine—Loss of consciousness—Prednisone—ulcerative colitis	5.28e-05	0.000198	CcSEcCtD
Paroxetine—Hypotension—Betamethasone—ulcerative colitis	5.26e-05	0.000197	CcSEcCtD
Paroxetine—Hypotension—Dexamethasone—ulcerative colitis	5.26e-05	0.000197	CcSEcCtD
Paroxetine—Urticaria—Hydrocortisone—ulcerative colitis	5.23e-05	0.000196	CcSEcCtD
Paroxetine—Body temperature increased—Hydrocortisone—ulcerative colitis	5.2e-05	0.000195	CcSEcCtD
Paroxetine—Abdominal pain—Hydrocortisone—ulcerative colitis	5.2e-05	0.000195	CcSEcCtD
Paroxetine—Convulsion—Prednisone—ulcerative colitis	5.2e-05	0.000195	CcSEcCtD
Paroxetine—Hypertension—Prednisone—ulcerative colitis	5.18e-05	0.000194	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	5.12e-05	0.000192	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	5.12e-05	0.000192	CcSEcCtD
Paroxetine—Myalgia—Prednisone—ulcerative colitis	5.11e-05	0.000191	CcSEcCtD
Paroxetine—Arthralgia—Prednisone—ulcerative colitis	5.11e-05	0.000191	CcSEcCtD
Paroxetine—Feeling abnormal—Triamcinolone—ulcerative colitis	5.11e-05	0.000191	CcSEcCtD
Paroxetine—Feeling abnormal—Methylprednisolone—ulcerative colitis	5.1e-05	0.000191	CcSEcCtD
Paroxetine—Anxiety—Prednisone—ulcerative colitis	5.09e-05	0.000191	CcSEcCtD
Paroxetine—Insomnia—Betamethasone—ulcerative colitis	5.09e-05	0.000191	CcSEcCtD
Paroxetine—Insomnia—Dexamethasone—ulcerative colitis	5.09e-05	0.000191	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	5.07e-05	0.00019	CcSEcCtD
Paroxetine—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	5.06e-05	0.000189	CcSEcCtD
Paroxetine—Paraesthesia—Betamethasone—ulcerative colitis	5.05e-05	0.000189	CcSEcCtD
Paroxetine—Paraesthesia—Dexamethasone—ulcerative colitis	5.05e-05	0.000189	CcSEcCtD
Paroxetine—Discomfort—Prednisone—ulcerative colitis	5.05e-05	0.000189	CcSEcCtD
Paroxetine—Hypersensitivity—Prednisolone—ulcerative colitis	4.97e-05	0.000186	CcSEcCtD
Paroxetine—Dyspepsia—Dexamethasone—ulcerative colitis	4.95e-05	0.000185	CcSEcCtD
Paroxetine—Dyspepsia—Betamethasone—ulcerative colitis	4.95e-05	0.000185	CcSEcCtD
Paroxetine—Urticaria—Triamcinolone—ulcerative colitis	4.92e-05	0.000184	CcSEcCtD
Paroxetine—Urticaria—Methylprednisolone—ulcerative colitis	4.91e-05	0.000184	CcSEcCtD
Paroxetine—Body temperature increased—Triamcinolone—ulcerative colitis	4.9e-05	0.000184	CcSEcCtD
Paroxetine—Oedema—Prednisone—ulcerative colitis	4.9e-05	0.000183	CcSEcCtD
Paroxetine—Anaphylactic shock—Prednisone—ulcerative colitis	4.9e-05	0.000183	CcSEcCtD
Paroxetine—Abdominal pain—Methylprednisolone—ulcerative colitis	4.89e-05	0.000183	CcSEcCtD
Paroxetine—Decreased appetite—Dexamethasone—ulcerative colitis	4.89e-05	0.000183	CcSEcCtD
Paroxetine—Decreased appetite—Betamethasone—ulcerative colitis	4.89e-05	0.000183	CcSEcCtD
Paroxetine—Infection—Prednisone—ulcerative colitis	4.87e-05	0.000182	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Betamethasone—ulcerative colitis	4.86e-05	0.000182	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	4.86e-05	0.000182	CcSEcCtD
Paroxetine—Hypersensitivity—Hydrocortisone—ulcerative colitis	4.85e-05	0.000182	CcSEcCtD
Paroxetine—Fatigue—Betamethasone—ulcerative colitis	4.85e-05	0.000182	CcSEcCtD
Paroxetine—Fatigue—Dexamethasone—ulcerative colitis	4.85e-05	0.000182	CcSEcCtD
Paroxetine—Shock—Prednisone—ulcerative colitis	4.82e-05	0.000181	CcSEcCtD
Paroxetine—Pain—Betamethasone—ulcerative colitis	4.81e-05	0.00018	CcSEcCtD
Paroxetine—Pain—Dexamethasone—ulcerative colitis	4.81e-05	0.00018	CcSEcCtD
Paroxetine—Nervous system disorder—Prednisone—ulcerative colitis	4.8e-05	0.00018	CcSEcCtD
Paroxetine—Tachycardia—Prednisone—ulcerative colitis	4.78e-05	0.000179	CcSEcCtD
Paroxetine—Skin disorder—Prednisone—ulcerative colitis	4.76e-05	0.000178	CcSEcCtD
Paroxetine—Hyperhidrosis—Prednisone—ulcerative colitis	4.74e-05	0.000177	CcSEcCtD
Paroxetine—Asthenia—Hydrocortisone—ulcerative colitis	4.72e-05	0.000177	CcSEcCtD
Paroxetine—Pruritus—Hydrocortisone—ulcerative colitis	4.66e-05	0.000174	CcSEcCtD
Paroxetine—Feeling abnormal—Dexamethasone—ulcerative colitis	4.64e-05	0.000174	CcSEcCtD
Paroxetine—Feeling abnormal—Betamethasone—ulcerative colitis	4.64e-05	0.000174	CcSEcCtD
Paroxetine—Gastrointestinal pain—Dexamethasone—ulcerative colitis	4.6e-05	0.000172	CcSEcCtD
Paroxetine—Gastrointestinal pain—Betamethasone—ulcerative colitis	4.6e-05	0.000172	CcSEcCtD
Paroxetine—Hypersensitivity—Triamcinolone—ulcerative colitis	4.57e-05	0.000171	CcSEcCtD
Paroxetine—Hypersensitivity—Methylprednisolone—ulcerative colitis	4.56e-05	0.000171	CcSEcCtD
Paroxetine—Diarrhoea—Hydrocortisone—ulcerative colitis	4.5e-05	0.000169	CcSEcCtD
Paroxetine—Urticaria—Dexamethasone—ulcerative colitis	4.47e-05	0.000167	CcSEcCtD
Paroxetine—Urticaria—Betamethasone—ulcerative colitis	4.47e-05	0.000167	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Prednisone—ulcerative colitis	4.46e-05	0.000167	CcSEcCtD
Paroxetine—Dizziness—Prednisolone—ulcerative colitis	4.46e-05	0.000167	CcSEcCtD
Paroxetine—Asthenia—Triamcinolone—ulcerative colitis	4.45e-05	0.000167	CcSEcCtD
Paroxetine—Abdominal pain—Dexamethasone—ulcerative colitis	4.45e-05	0.000167	CcSEcCtD
Paroxetine—Abdominal pain—Betamethasone—ulcerative colitis	4.45e-05	0.000167	CcSEcCtD
Paroxetine—Body temperature increased—Betamethasone—ulcerative colitis	4.45e-05	0.000167	CcSEcCtD
Paroxetine—Body temperature increased—Dexamethasone—ulcerative colitis	4.45e-05	0.000167	CcSEcCtD
Paroxetine—Asthenia—Methylprednisolone—ulcerative colitis	4.44e-05	0.000166	CcSEcCtD
Paroxetine—Insomnia—Prednisone—ulcerative colitis	4.43e-05	0.000166	CcSEcCtD
Paroxetine—Paraesthesia—Prednisone—ulcerative colitis	4.4e-05	0.000165	CcSEcCtD
Paroxetine—Pruritus—Triamcinolone—ulcerative colitis	4.39e-05	0.000164	CcSEcCtD
Paroxetine—Pruritus—Methylprednisolone—ulcerative colitis	4.38e-05	0.000164	CcSEcCtD
Paroxetine—Dizziness—Hydrocortisone—ulcerative colitis	4.35e-05	0.000163	CcSEcCtD
Paroxetine—Dyspepsia—Prednisone—ulcerative colitis	4.31e-05	0.000162	CcSEcCtD
Paroxetine—Decreased appetite—Prednisone—ulcerative colitis	4.26e-05	0.000159	CcSEcCtD
Paroxetine—Rash—Prednisolone—ulcerative colitis	4.25e-05	0.000159	CcSEcCtD
Paroxetine—Dermatitis—Prednisolone—ulcerative colitis	4.25e-05	0.000159	CcSEcCtD
Paroxetine—Diarrhoea—Methylprednisolone—ulcerative colitis	4.23e-05	0.000159	CcSEcCtD
Paroxetine—Fatigue—Prednisone—ulcerative colitis	4.22e-05	0.000158	CcSEcCtD
Paroxetine—Headache—Prednisolone—ulcerative colitis	4.22e-05	0.000158	CcSEcCtD
Paroxetine—Constipation—Prednisone—ulcerative colitis	4.19e-05	0.000157	CcSEcCtD
Paroxetine—Vomiting—Hydrocortisone—ulcerative colitis	4.19e-05	0.000157	CcSEcCtD
Paroxetine—Rash—Hydrocortisone—ulcerative colitis	4.15e-05	0.000155	CcSEcCtD
Paroxetine—Dermatitis—Hydrocortisone—ulcerative colitis	4.15e-05	0.000155	CcSEcCtD
Paroxetine—Headache—Hydrocortisone—ulcerative colitis	4.12e-05	0.000154	CcSEcCtD
Paroxetine—Dizziness—Triamcinolone—ulcerative colitis	4.1e-05	0.000154	CcSEcCtD
Paroxetine—Dizziness—Methylprednisolone—ulcerative colitis	4.09e-05	0.000153	CcSEcCtD
Paroxetine—Feeling abnormal—Prednisone—ulcerative colitis	4.04e-05	0.000151	CcSEcCtD
Paroxetine—Asthenia—Dexamethasone—ulcerative colitis	4.04e-05	0.000151	CcSEcCtD
Paroxetine—Asthenia—Betamethasone—ulcerative colitis	4.04e-05	0.000151	CcSEcCtD
Paroxetine—Gastrointestinal pain—Prednisone—ulcerative colitis	4.01e-05	0.00015	CcSEcCtD
Paroxetine—Nausea—Prednisolone—ulcerative colitis	4e-05	0.00015	CcSEcCtD
Paroxetine—Pruritus—Dexamethasone—ulcerative colitis	3.98e-05	0.000149	CcSEcCtD
Paroxetine—Pruritus—Betamethasone—ulcerative colitis	3.98e-05	0.000149	CcSEcCtD
Paroxetine—Vomiting—Triamcinolone—ulcerative colitis	3.94e-05	0.000148	CcSEcCtD
Paroxetine—Vomiting—Methylprednisolone—ulcerative colitis	3.93e-05	0.000147	CcSEcCtD
Paroxetine—Nausea—Hydrocortisone—ulcerative colitis	3.91e-05	0.000146	CcSEcCtD
Paroxetine—Rash—Triamcinolone—ulcerative colitis	3.91e-05	0.000146	CcSEcCtD
Paroxetine—Dermatitis—Triamcinolone—ulcerative colitis	3.9e-05	0.000146	CcSEcCtD
Paroxetine—Rash—Methylprednisolone—ulcerative colitis	3.9e-05	0.000146	CcSEcCtD
Paroxetine—Dermatitis—Methylprednisolone—ulcerative colitis	3.9e-05	0.000146	CcSEcCtD
Paroxetine—Urticaria—Prednisone—ulcerative colitis	3.89e-05	0.000146	CcSEcCtD
Paroxetine—Headache—Triamcinolone—ulcerative colitis	3.88e-05	0.000145	CcSEcCtD
Paroxetine—Headache—Methylprednisolone—ulcerative colitis	3.87e-05	0.000145	CcSEcCtD
Paroxetine—Body temperature increased—Prednisone—ulcerative colitis	3.87e-05	0.000145	CcSEcCtD
Paroxetine—Abdominal pain—Prednisone—ulcerative colitis	3.87e-05	0.000145	CcSEcCtD
Paroxetine—Diarrhoea—Dexamethasone—ulcerative colitis	3.85e-05	0.000144	CcSEcCtD
Paroxetine—Diarrhoea—Betamethasone—ulcerative colitis	3.85e-05	0.000144	CcSEcCtD
Paroxetine—Dizziness—Dexamethasone—ulcerative colitis	3.72e-05	0.000139	CcSEcCtD
Paroxetine—Dizziness—Betamethasone—ulcerative colitis	3.72e-05	0.000139	CcSEcCtD
Paroxetine—Nausea—Triamcinolone—ulcerative colitis	3.68e-05	0.000138	CcSEcCtD
Paroxetine—Nausea—Methylprednisolone—ulcerative colitis	3.67e-05	0.000138	CcSEcCtD
Paroxetine—Hypersensitivity—Prednisone—ulcerative colitis	3.61e-05	0.000135	CcSEcCtD
Paroxetine—Vomiting—Dexamethasone—ulcerative colitis	3.58e-05	0.000134	CcSEcCtD
Paroxetine—Vomiting—Betamethasone—ulcerative colitis	3.58e-05	0.000134	CcSEcCtD
Paroxetine—Rash—Dexamethasone—ulcerative colitis	3.55e-05	0.000133	CcSEcCtD
Paroxetine—Rash—Betamethasone—ulcerative colitis	3.55e-05	0.000133	CcSEcCtD
Paroxetine—Dermatitis—Betamethasone—ulcerative colitis	3.54e-05	0.000133	CcSEcCtD
Paroxetine—Dermatitis—Dexamethasone—ulcerative colitis	3.54e-05	0.000133	CcSEcCtD
Paroxetine—Headache—Dexamethasone—ulcerative colitis	3.52e-05	0.000132	CcSEcCtD
Paroxetine—Headache—Betamethasone—ulcerative colitis	3.52e-05	0.000132	CcSEcCtD
Paroxetine—Asthenia—Prednisone—ulcerative colitis	3.51e-05	0.000132	CcSEcCtD
Paroxetine—Pruritus—Prednisone—ulcerative colitis	3.47e-05	0.00013	CcSEcCtD
Paroxetine—Diarrhoea—Prednisone—ulcerative colitis	3.35e-05	0.000126	CcSEcCtD
Paroxetine—Nausea—Dexamethasone—ulcerative colitis	3.34e-05	0.000125	CcSEcCtD
Paroxetine—Nausea—Betamethasone—ulcerative colitis	3.34e-05	0.000125	CcSEcCtD
Paroxetine—Dizziness—Prednisone—ulcerative colitis	3.24e-05	0.000121	CcSEcCtD
Paroxetine—Vomiting—Prednisone—ulcerative colitis	3.11e-05	0.000117	CcSEcCtD
Paroxetine—Rash—Prednisone—ulcerative colitis	3.09e-05	0.000116	CcSEcCtD
Paroxetine—Dermatitis—Prednisone—ulcerative colitis	3.09e-05	0.000116	CcSEcCtD
Paroxetine—Headache—Prednisone—ulcerative colitis	3.07e-05	0.000115	CcSEcCtD
Paroxetine—Nausea—Prednisone—ulcerative colitis	2.91e-05	0.000109	CcSEcCtD
Paroxetine—CHRM2—Signaling by GPCR—CALM3—ulcerative colitis	2.18e-05	0.000329	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—DLD—ulcerative colitis	2.14e-05	0.000323	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—DLD—ulcerative colitis	2.12e-05	0.00032	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—ADRB2—ulcerative colitis	2.09e-05	0.000316	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—PTGER4—ulcerative colitis	2.09e-05	0.000316	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—ADRB2—ulcerative colitis	2.08e-05	0.000314	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—ADRB2—ulcerative colitis	2.07e-05	0.000313	CbGpPWpGaD
Paroxetine—SLC6A3—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.06e-05	0.000312	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—ADRB2—ulcerative colitis	2.05e-05	0.00031	CbGpPWpGaD
Paroxetine—CHRM1—Circadian rythm related genes—TP53—ulcerative colitis	2.04e-05	0.000308	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCL20—ulcerative colitis	2e-05	0.000303	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—GHRL—ulcerative colitis	2e-05	0.000302	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCL20—ulcerative colitis	1.99e-05	0.000301	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCL20—ulcerative colitis	1.99e-05	0.0003	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCL20—ulcerative colitis	1.97e-05	0.000298	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.96e-05	0.000296	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CALM3—ulcerative colitis	1.93e-05	0.000292	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—GHRL—ulcerative colitis	1.91e-05	0.000289	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—RIPK2—ulcerative colitis	1.91e-05	0.000288	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—JAK2—ulcerative colitis	1.91e-05	0.000288	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—ADRB2—ulcerative colitis	1.9e-05	0.000287	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—ADRB2—ulcerative colitis	1.89e-05	0.000285	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—GNA12—ulcerative colitis	1.88e-05	0.000285	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—ADRB2—ulcerative colitis	1.88e-05	0.000284	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—GNA12—ulcerative colitis	1.87e-05	0.000283	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—GNA12—ulcerative colitis	1.87e-05	0.000282	CbGpPWpGaD
Paroxetine—CHRM1—Circadian rythm related genes—IL6—ulcerative colitis	1.87e-05	0.000282	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—ADRB2—ulcerative colitis	1.86e-05	0.000282	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CALM3—ulcerative colitis	1.85e-05	0.00028	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—GNA12—ulcerative colitis	1.85e-05	0.00028	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—RELA—ulcerative colitis	1.85e-05	0.000279	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—RIPK2—ulcerative colitis	1.82e-05	0.000276	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CXCR2—ulcerative colitis	1.79e-05	0.00027	CbGpPWpGaD
Paroxetine—HTR2A—GPCR ligand binding—CXCL8—ulcerative colitis	1.79e-05	0.00027	CbGpPWpGaD
Paroxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	1.78e-05	0.000269	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CXCR2—ulcerative colitis	1.78e-05	0.000269	CbGpPWpGaD
Paroxetine—CHRM1—GPCR ligand binding—CXCL8—ulcerative colitis	1.78e-05	0.000268	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—ADCY5—ulcerative colitis	1.77e-05	0.000268	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CXCR2—ulcerative colitis	1.77e-05	0.000268	CbGpPWpGaD
Paroxetine—CHRM3—GPCR ligand binding—CXCL8—ulcerative colitis	1.77e-05	0.000268	CbGpPWpGaD
Paroxetine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	1.77e-05	0.000267	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—ADCY5—ulcerative colitis	1.76e-05	0.000267	CbGpPWpGaD
Paroxetine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	1.76e-05	0.000267	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—ADCY5—ulcerative colitis	1.76e-05	0.000266	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CXCR2—ulcerative colitis	1.75e-05	0.000265	CbGpPWpGaD
Paroxetine—CHRM2—GPCR ligand binding—CXCL8—ulcerative colitis	1.75e-05	0.000265	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—ADCY5—ulcerative colitis	1.74e-05	0.000263	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—CXCL8—ulcerative colitis	1.74e-05	0.000263	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PTGS1—ulcerative colitis	1.73e-05	0.000261	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCR6—ulcerative colitis	1.68e-05	0.000254	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCR6—ulcerative colitis	1.67e-05	0.000253	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCR6—ulcerative colitis	1.67e-05	0.000252	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—IL2—ulcerative colitis	1.66e-05	0.000251	CbGpPWpGaD
Paroxetine—TACR1—Signaling by GPCR—IL6—ulcerative colitis	1.65e-05	0.00025	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—ADRB2—ulcerative colitis	1.65e-05	0.00025	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCR6—ulcerative colitis	1.65e-05	0.000249	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.63e-05	0.000247	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—JAK2—ulcerative colitis	1.63e-05	0.000247	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—ADCY5—ulcerative colitis	1.61e-05	0.000243	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—ADCY5—ulcerative colitis	1.6e-05	0.000242	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—ADCY5—ulcerative colitis	1.6e-05	0.000241	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MAML2—ulcerative colitis	1.59e-05	0.000241	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MAML2—ulcerative colitis	1.58e-05	0.000239	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—ADRB2—ulcerative colitis	1.58e-05	0.000239	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—ADCY5—ulcerative colitis	1.58e-05	0.000239	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MAML2—ulcerative colitis	1.58e-05	0.000239	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—MMP9—ulcerative colitis	1.57e-05	0.000238	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MAML2—ulcerative colitis	1.56e-05	0.000236	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—JAK2—ulcerative colitis	1.56e-05	0.000236	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—NFKB1—ulcerative colitis	1.56e-05	0.000235	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—CALM3—ulcerative colitis	1.55e-05	0.000235	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.53e-05	0.000231	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.52e-05	0.00023	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—CXCL8—ulcerative colitis	1.49e-05	0.000225	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PTGS1—ulcerative colitis	1.49e-05	0.000225	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—JAK2—ulcerative colitis	1.48e-05	0.000224	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PTGER4—ulcerative colitis	1.48e-05	0.000224	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PTGER4—ulcerative colitis	1.47e-05	0.000222	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PTGER4—ulcerative colitis	1.47e-05	0.000222	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PTGER4—ulcerative colitis	1.45e-05	0.00022	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—CXCL8—ulcerative colitis	1.43e-05	0.000215	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—IL2—ulcerative colitis	1.42e-05	0.000215	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—JAK2—ulcerative colitis	1.42e-05	0.000214	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—ADCY5—ulcerative colitis	1.4e-05	0.000212	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—STAT3—ulcerative colitis	1.4e-05	0.000211	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.38e-05	0.000208	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—IL2—ulcerative colitis	1.36e-05	0.000206	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—GHRL—ulcerative colitis	1.35e-05	0.000205	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—CXCL8—ulcerative colitis	1.35e-05	0.000204	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—GHRL—ulcerative colitis	1.35e-05	0.000204	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.34e-05	0.000203	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—ADCY5—ulcerative colitis	1.34e-05	0.000203	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—GHRL—ulcerative colitis	1.34e-05	0.000203	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—CALM3—ulcerative colitis	1.34e-05	0.000202	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—GHRL—ulcerative colitis	1.33e-05	0.000201	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CALM3—ulcerative colitis	1.31e-05	0.000198	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CALM3—ulcerative colitis	1.3e-05	0.000197	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CALM3—ulcerative colitis	1.3e-05	0.000197	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—TGFB1—ulcerative colitis	1.3e-05	0.000196	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—CXCL8—ulcerative colitis	1.29e-05	0.000196	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—IL2—ulcerative colitis	1.29e-05	0.000195	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—RIPK2—ulcerative colitis	1.29e-05	0.000195	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CALM3—ulcerative colitis	1.29e-05	0.000195	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—RIPK2—ulcerative colitis	1.28e-05	0.000194	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—RIPK2—ulcerative colitis	1.28e-05	0.000194	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—RIPK2—ulcerative colitis	1.27e-05	0.000192	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PTGS1—ulcerative colitis	1.26e-05	0.00019	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.24e-05	0.000187	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—IL2—ulcerative colitis	1.24e-05	0.000187	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—ABCB1—ulcerative colitis	1.21e-05	0.000183	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CALM3—ulcerative colitis	1.13e-05	0.000171	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—ADCY5—ulcerative colitis	1.13e-05	0.000171	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—ADRB2—ulcerative colitis	1.12e-05	0.000169	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.12e-05	0.000169	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—ADRB2—ulcerative colitis	1.11e-05	0.000169	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—ADRB2—ulcerative colitis	1.11e-05	0.000168	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—JAK2—ulcerative colitis	1.11e-05	0.000167	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—ADRB2—ulcerative colitis	1.1e-05	0.000166	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—JAK2—ulcerative colitis	1.1e-05	0.000166	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—JAK2—ulcerative colitis	1.1e-05	0.000166	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PTGS1—ulcerative colitis	1.1e-05	0.000166	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—JAK2—ulcerative colitis	1.09e-05	0.000164	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.08e-05	0.000164	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—TP53—ulcerative colitis	1.07e-05	0.000161	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—ABCB1—ulcerative colitis	1.04e-05	0.000157	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PTGS1—ulcerative colitis	1.03e-05	0.000156	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.02e-05	0.000155	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PTGS1—ulcerative colitis	1.02e-05	0.000155	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—CXCL8—ulcerative colitis	1.01e-05	0.000153	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.01e-05	0.000152	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—JAK2—ulcerative colitis	1e-05	0.000152	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—CXCL8—ulcerative colitis	1e-05	0.000152	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—CXCL8—ulcerative colitis	1e-05	0.000151	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—JAK2—ulcerative colitis	9.98e-06	0.000151	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—JAK2—ulcerative colitis	9.95e-06	0.00015	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—CXCL8—ulcerative colitis	9.91e-06	0.00015	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CALM3—ulcerative colitis	9.86e-06	0.000149	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—JAK2—ulcerative colitis	9.86e-06	0.000149	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—IL6—ulcerative colitis	9.77e-06	0.000148	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—ADCY5—ulcerative colitis	9.7e-06	0.000147	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—IL2—ulcerative colitis	9.64e-06	0.000146	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—IL2—ulcerative colitis	9.59e-06	0.000145	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—IL2—ulcerative colitis	9.56e-06	0.000145	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—ADCY5—ulcerative colitis	9.51e-06	0.000144	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—IL2—ulcerative colitis	9.47e-06	0.000143	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—ADCY5—ulcerative colitis	9.46e-06	0.000143	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—ADCY5—ulcerative colitis	9.43e-06	0.000143	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—ADCY5—ulcerative colitis	9.34e-06	0.000141	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CALM3—ulcerative colitis	9.3e-06	0.000141	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CALM3—ulcerative colitis	9.22e-06	0.000139	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—CXCL8—ulcerative colitis	9.16e-06	0.000139	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—CXCL8—ulcerative colitis	9.11e-06	0.000138	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—CXCL8—ulcerative colitis	9.08e-06	0.000137	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—CXCL8—ulcerative colitis	9e-06	0.000136	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	8.81e-06	0.000133	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ABCB1—ulcerative colitis	8.81e-06	0.000133	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL2—ulcerative colitis	8.76e-06	0.000132	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—JAK2—ulcerative colitis	8.75e-06	0.000132	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL2—ulcerative colitis	8.71e-06	0.000132	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL2—ulcerative colitis	8.68e-06	0.000131	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL2—ulcerative colitis	8.6e-06	0.00013	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—RELA—ulcerative colitis	8.47e-06	0.000128	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PPARG—ulcerative colitis	8.41e-06	0.000127	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—JAK2—ulcerative colitis	8.38e-06	0.000127	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ADCY5—ulcerative colitis	8.21e-06	0.000124	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—RELA—ulcerative colitis	8.11e-06	0.000123	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CXCL8—ulcerative colitis	7.98e-06	0.000121	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CXCL8—ulcerative colitis	7.65e-06	0.000116	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL2—ulcerative colitis	7.63e-06	0.000115	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—IL6—ulcerative colitis	7.59e-06	0.000115	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—ALB—ulcerative colitis	7.56e-06	0.000114	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL2—ulcerative colitis	7.31e-06	0.00011	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—IL6—ulcerative colitis	7.27e-06	0.00011	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PPARG—ulcerative colitis	7.24e-06	0.000109	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ABCB1—ulcerative colitis	7.23e-06	0.000109	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—MMP9—ulcerative colitis	7.22e-06	0.000109	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ABCB1—ulcerative colitis	7.17e-06	0.000108	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ADCY5—ulcerative colitis	7.16e-06	0.000108	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—NFKB1—ulcerative colitis	7.14e-06	0.000108	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—MMP9—ulcerative colitis	6.92e-06	0.000105	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—NFKB1—ulcerative colitis	6.84e-06	0.000103	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ADCY5—ulcerative colitis	6.74e-06	0.000102	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ADCY5—ulcerative colitis	6.69e-06	0.000101	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PTGS2—ulcerative colitis	6.62e-06	0.0001	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—ALB—ulcerative colitis	6.51e-06	9.84e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—STAT3—ulcerative colitis	6.42e-06	9.71e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—STAT3—ulcerative colitis	6.15e-06	9.3e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PPARG—ulcerative colitis	6.13e-06	9.26e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TGFB1—ulcerative colitis	5.95e-06	9e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—JAK2—ulcerative colitis	5.93e-06	8.97e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—JAK2—ulcerative colitis	5.9e-06	8.92e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—JAK2—ulcerative colitis	5.88e-06	8.89e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—JAK2—ulcerative colitis	5.82e-06	8.8e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—RELA—ulcerative colitis	5.74e-06	8.68e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—RELA—ulcerative colitis	5.71e-06	8.64e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TGFB1—ulcerative colitis	5.7e-06	8.62e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—RELA—ulcerative colitis	5.69e-06	8.61e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PTGS2—ulcerative colitis	5.69e-06	8.61e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—RELA—ulcerative colitis	5.64e-06	8.53e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ALB—ulcerative colitis	5.51e-06	8.33e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CXCL8—ulcerative colitis	5.41e-06	8.18e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CXCL8—ulcerative colitis	5.38e-06	8.14e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CXCL8—ulcerative colitis	5.37e-06	8.11e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PPARG—ulcerative colitis	5.34e-06	8.07e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CXCL8—ulcerative colitis	5.31e-06	8.03e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL2—ulcerative colitis	5.17e-06	7.82e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL6—ulcerative colitis	5.15e-06	7.78e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL2—ulcerative colitis	5.14e-06	7.78e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL2—ulcerative colitis	5.13e-06	7.75e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL6—ulcerative colitis	5.12e-06	7.74e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL6—ulcerative colitis	5.1e-06	7.71e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL2—ulcerative colitis	5.08e-06	7.68e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL6—ulcerative colitis	5.05e-06	7.64e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PPARG—ulcerative colitis	5.03e-06	7.6e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PPARG—ulcerative colitis	4.99e-06	7.54e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TP53—ulcerative colitis	4.9e-06	7.41e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MMP9—ulcerative colitis	4.9e-06	7.4e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MMP9—ulcerative colitis	4.87e-06	7.36e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MMP9—ulcerative colitis	4.85e-06	7.34e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NFKB1—ulcerative colitis	4.84e-06	7.32e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PTGS2—ulcerative colitis	4.82e-06	7.29e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NFKB1—ulcerative colitis	4.82e-06	7.28e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MMP9—ulcerative colitis	4.81e-06	7.27e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NFKB1—ulcerative colitis	4.8e-06	7.26e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ALB—ulcerative colitis	4.8e-06	7.26e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NFKB1—ulcerative colitis	4.76e-06	7.19e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TP53—ulcerative colitis	4.69e-06	7.09e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ALB—ulcerative colitis	4.52e-06	6.84e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL6—ulcerative colitis	4.48e-06	6.78e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ALB—ulcerative colitis	4.48e-06	6.78e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—STAT3—ulcerative colitis	4.35e-06	6.58e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—STAT3—ulcerative colitis	4.33e-06	6.55e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—STAT3—ulcerative colitis	4.32e-06	6.52e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL6—ulcerative colitis	4.29e-06	6.49e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—STAT3—ulcerative colitis	4.27e-06	6.46e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PTGS2—ulcerative colitis	4.2e-06	6.35e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TGFB1—ulcerative colitis	4.03e-06	6.1e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TGFB1—ulcerative colitis	4.01e-06	6.07e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TGFB1—ulcerative colitis	4e-06	6.05e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TGFB1—ulcerative colitis	3.96e-06	5.99e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PTGS2—ulcerative colitis	3.96e-06	5.98e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PTGS2—ulcerative colitis	3.92e-06	5.93e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TP53—ulcerative colitis	3.32e-06	5.02e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TP53—ulcerative colitis	3.3e-06	4.99e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TP53—ulcerative colitis	3.29e-06	4.98e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TP53—ulcerative colitis	3.26e-06	4.93e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL6—ulcerative colitis	3.04e-06	4.6e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL6—ulcerative colitis	3.02e-06	4.57e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL6—ulcerative colitis	3.01e-06	4.56e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL6—ulcerative colitis	2.99e-06	4.51e-05	CbGpPWpGaD
